The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20261576: Bells Aggregator Limited Partnership; Phased Right Incorporated
20261584: Warren Equity Partners Fund IV, L.P.; Guardian Capital Partners Fund III (Q), L.P.
20261592: EQT Active Core Infrastructure (No.3) SCSp; Americold Realty Trust, Inc.
20261600: Mill Point Capital Partners III, L.P.; Total Safety Holdings LLC
20261601: Elon Musk; Mesh Optical Technologies Corporation
20261605: TPG Growth VI DE AIV I, LP; Broad Sky Partners, LP
20261611: Lennox International Inc.; Platinum Equity Small Cap Fund II, L.P. c/o Platinum Equity
20261618: Harvest Partners IX (Parallel), L.P.; Keystone Capital Fund II, LP
CareFirst of Maryland, et al., Plaintiffs-Appellants, v. Johnson & Johnson, et al., Defendants-Appellees.
Rollins Inc., In the Matter of
Jena Antonucci, In the Matter of
Aurobindo-Lannett, In the Matter of
The FTC is requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc.
Growthmind/Wisey
At the Federal Trade Commission’s request, a federal court has temporarily halted a sprawling enterprise of deceptive subscription schemes—comprised of 15 corporations and eight individuals—from continuing to deceive consumers with hidden costs and recurring charges, while failing to provide simple mechanisms to cancel subscriptions.
WPATH, FTC v.
The Federal Trade Commission, along with Alaska, Iowa, Nebraska and Texas, today filed a lawsuit against the World Professional Association for Transgender Health (WPATH), alleging the organization has provided the means for medical providers to make false and unsubstantiated claims to parents in order to sell pediatric medical transition services.